HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Association of acquired von Willebrand syndrome with AL amyloidosis.

AbstractAcquired loss of functional von Willebrand factor (VWF) has been termed the acquired von Willebrand syndrome (AVWS). AVWS is a rare adult-onset bleeding diathesis that is clinically similar to congenital von Willebrand disease (VWD), and occurs with a variety of autoimmune, lymphoproliferative, or myeloproliferative disorders. We have identified four patients with AVWS in association with immunoglobulin light chain (AL) amyloidosis. These patients, lacking any pre-existing or family history of abnormal bleeding, developed cutaneous, mucosal, or gastrointestinal bleeding in the course of their disease without deficiency of clotting factor X or other factors; the activated partial thromboplastin time (aPTT) was prolonged in three out of the four cases. Despite normal VWF antigen levels, VWF ristocetin cofactor activity (VWF:RCo) was low. Electrophoresis patterns of high molecular weight (HMW) VWF multimers were abnormal in two of the four cases. Two of the patients were treated with high-dose intravenous melphalan followed by autologous stem cell transplantation (HDM/SCT) and achieved hematologic remission. In these two patients, the bleeding diathesis improved and the coagulation parameters normalized, confirming a causal relationship between the plasma cell dyscrasia and the AVWS. AVWS should be considered in AL amyloidosis patients with hemorrhagic diatheses and normal clotting factor levels.
AuthorsCynthia A Kos, Jennifer E Ward, Karim Malek, Vaishali Sanchorawala, Daniel G Wright, Carl O'Hara, Lawreen Connors, Martha Skinner, David C Seldin (Affiliation: Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA.)
JournalAmerican journal of hematology (Am J Hematol) Vol. 82 Issue 5 Pg. 363-7 (May 2007) ISSN: 0361-8609 [Print] United States
PMID17205535 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright(c) 2007 Wiley-Liss, Inc.
Chemical References
  • Antigens
  • Immunoglobulin Light Chains
  • Von Willebrand antigen
  • von Willebrand Factor
  • Ristocetin
  • Melphalan
Topics
  • Adult
  • Amyloidosis (blood, complications, drug therapy, surgery)
  • Antigens (analysis)
  • Blood Protein Electrophoresis
  • Electrophoresis, Agar Gel
  • Hemorrhage (etiology)
  • Humans
  • Immunoglobulin Light Chains (analysis)
  • Male
  • Melphalan (therapeutic use)
  • Molecular Weight
  • Partial Thromboplastin Time
  • Peripheral Blood Stem Cell Transplantation
  • Remission Induction
  • Ristocetin (pharmacology)
  • Transplantation, Autologous
  • von Willebrand Diseases (etiology, immunology)
  • von Willebrand Factor (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD